drugset / Trial / NCT00338130
Randomised Study to Compare the Efficacy of AZD6244 vs TMZ
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary purpose of this study is to compare the efficacy of AZD6244 (ARRY-142886) with temozolomide in patients with advanced melanoma
Timeline
- Start
- 2006-07
- Primary completion
- 2007-09
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Selumetinib | Small molecule | — | Oral |
| Comparator | Temozolomide | Small molecule | — | Oral |